Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Montana

Showing results (41-50 of 59) with videos related to

Pageof 6
Sort By:
Epidemiology and Psychiatric Sciences|March 30, 2022
Parental education and youth suicidal behaviours: a systematic review and meta-analysisP J Chen, N Mackes, C Sacchi, et al.
Toxicology and Applied Pharmacology|August 5, 2008
Action of (R)-sila-venlafaxine and reboxetine to antagonize cisplatin-induced acute and delayed emesis in the ferretJulie B Warneck, Frankie H M Cheng, Matthew J Barnes, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Synthesis and evaluation of a novel series of phosphodiesterase IV inhibitors. A potential treatment for asthmaS C Beasley, N Cooper, L Gowers, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 8, 2001
Structural determinants of ligand binding selectivity between the peroxisome proliferator-activated receptorsH E Xu, M H Lambert, V G Montana, et al.
Molecular Cell|April 13, 1999
Molecular recognition of fatty acids by peroxisome proliferator-activated receptorsH E Xu, M H Lambert, V G Montana, et al.
Bioorganic & Medicinal Chemistry Letters|April 18, 2003
Novel selective small molecule agonists for peroxisome proliferator-activated receptor delta (PPARdelta)--synthesis and biological activityMarcos L Sznaidman, Curt D Haffner, Patrick R Maloney, et al.
Bioorganic & Medicinal Chemistry Letters|May 1, 2001
Synthesis and structure-activity relationships of guanine analogues as phosphodiesterase 7 (PDE7) inhibitorsM J Barnes, N Cooper, R J Davenport, et al.
Journal of Medicinal Chemistry|April 2, 2004
Structure-based design of potent retinoid X receptor alpha agonistsCurt D Haffner, James M Lenhard, Aaron B Miller, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Aryl sulfonamides as selective PDE4 inhibitorsJ G Montana, G M Buckley, N Cooper, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
5,5-trans lactone-containing inhibitors of serine proteases: identification of a novel, acylating thrombin inhibitorH Finch, N A Pegg, J McLaren, et al.
Pageof 6

Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
Epidemiology and Psychiatric Sciences|March 30, 2022
Parental education and youth suicidal behaviours: a systematic review and meta-analysisP J Chen, N Mackes, C Sacchi, et al.
Toxicology and Applied Pharmacology|August 5, 2008
Action of (R)-sila-venlafaxine and reboxetine to antagonize cisplatin-induced acute and delayed emesis in the ferretJulie B Warneck, Frankie H M Cheng, Matthew J Barnes, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Synthesis and evaluation of a novel series of phosphodiesterase IV inhibitors. A potential treatment for asthmaS C Beasley, N Cooper, L Gowers, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 8, 2001
Structural determinants of ligand binding selectivity between the peroxisome proliferator-activated receptorsH E Xu, M H Lambert, V G Montana, et al.
Molecular Cell|April 13, 1999
Molecular recognition of fatty acids by peroxisome proliferator-activated receptorsH E Xu, M H Lambert, V G Montana, et al.
Bioorganic & Medicinal Chemistry Letters|April 18, 2003
Novel selective small molecule agonists for peroxisome proliferator-activated receptor delta (PPARdelta)--synthesis and biological activityMarcos L Sznaidman, Curt D Haffner, Patrick R Maloney, et al.
Bioorganic & Medicinal Chemistry Letters|May 1, 2001
Synthesis and structure-activity relationships of guanine analogues as phosphodiesterase 7 (PDE7) inhibitorsM J Barnes, N Cooper, R J Davenport, et al.
Journal of Medicinal Chemistry|April 2, 2004
Structure-based design of potent retinoid X receptor alpha agonistsCurt D Haffner, James M Lenhard, Aaron B Miller, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Aryl sulfonamides as selective PDE4 inhibitorsJ G Montana, G M Buckley, N Cooper, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
5,5-trans lactone-containing inhibitors of serine proteases: identification of a novel, acylating thrombin inhibitorH Finch, N A Pegg, J McLaren, et al.
Pageof 6